About Careers Internship MedBlog Contact us
Medindia LOGIN REGISTER
Advertisement

Breast Cancer Cells Allowed to Evade Tyrosine Kinase Inhibitors By New Class of Proteins

by Rukmani Krishna on August 15, 2012 at 11:26 PM
Font : A-A+

 Breast Cancer Cells Allowed to Evade Tyrosine Kinase Inhibitors By New Class of Proteins

Aberrant regulation of cell growth pathways is required for normal cells to become cancerous. In many types of cancer, cell growth is driven by a group of enzymes known as receptor tyrosine kinases (RTKs).

The RTK epidermal growth factor receptor (EGFR) is overexpressed in over 30% of breast cancers; however, drugs that target RTKs, known as tyrosine kinase inhibitors (TKIs) have not been effective in treating breast cancer. Researchers believe that the cancer cells escape TKIs by circumventing the RTKs and utilizing other enzymes that are not TKI-sensitive.

Advertisement

In the current issue of the Journal of Clinical Investigation, two groups identify a pair of related oncogenes, FAM83A and B, which allow breast cancer cells to survive TKI treatment. Researchers led by Mina Bissell at the Lawrence Berkeley National Laboratory in Berkeley, CA performed a screen of human breast cancer cell lines to identify genes that make cancer cells resistant to EGFR TKIs. Bissell and colleagues determined that increased expression of FAM83A increases proliferation and invasion, while decreased expression delays tumor growth in mice and renders cancer cells sensitive to TKIs. At Case Western Reserve Medical School in Cleveland, OH, Mark Jackson and colleagues identified FAM83B as a gene that allows normal human mammary cells to become malignant. Further, expression of FAM83A and B in human tumors was correlated with decreased overall survival. Taken together, these studies identify two genes that may serve as novel therapeutic targets. In a companion piece, Steven Grant of the Medical College of Virginia discusses the impact of this research on the development of strategies to overcome resistance to currently available TKIs.

Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
What's New on Medindia
Alarming Cesarean Section Trends in India - Convenience or Compulsion of Corporate Healthcare
Quiz on Low-Calorie Diet for Diabetes
World Heart Day in 2022- Use Heart for Every Heart
View all
Recommended Reading
News Archive
Date
Category
Advertisement
News Category

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Women and Cancer Breast Biopsy Pagets disease of the breast Mastitis Cancer and Homeopathy Parkinsons Disease Surgical Treatment Colorectal Cancer Breast Cancer Facts Cancer Facts Cancer 

Most Popular on Medindia

Blood Donation - Recipients Drug Side Effects Calculator Nutam (400mg) (Piracetam) Loram (2 mg) (Lorazepam) Find a Doctor Blood - Sugar Chart Daily Calorie Requirements Indian Medical Journals Accident and Trauma Care Drug - Food Interactions
This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use
×

Breast Cancer Cells Allowed to Evade Tyrosine Kinase Inhibitors By New Class of Proteins Personalised Printable Document (PDF)

Please complete this form and we'll send you a personalised information that is requested

You may use this for your own reference or forward it to your friends.

Please use the information prudently. If you are not a medical doctor please remember to consult your healthcare provider as this information is not a substitute for professional advice.

Name *

Email Address *

Country *

Areas of Interests